|
Vaccine Detail
DNA vaccine encoding ANDV glycoproteins |
Vaccine Information |
- Vaccine Name: DNA vaccine encoding ANDV glycoproteins
- Target Pathogen: Hantavirus
- Target Disease: Hantavirus Pulmonary Syndrome
- Vaccine Ontology ID: VO_0004119
- Type: DNA vaccine
- Antigen: Both the G1 and G2 glycoproteins are expressed (Custer et al., 2003).
- Hanta_G2
gene engineering:
- Type: Recombinant protein preparation
- Description: The Hantavirus G2 glycoprotein was expressed in the DNA vaccine (Custer et al., 2003).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000346
- Preparation: An expression plasmid, pWRG/AND-M, was constructed that contains the full-length M genome segment of Andes virus (ANDV), a South American hantavirus (Custer et al., 2003).
|
Host Response |
Macaque Response
- Vaccine Immune Response Type: VO_0000286
- Efficacy: Rhesus macaques vaccinated by gene gun with pWRG/AND-M developed remarkably high levels of neutralizing antibodies that not only neutralized ANDV (a South American hantavirus) but also cross-neutralized other HPS-associated hantaviruses, including Sin Nombre virus (Custer et al., 2003).
|
References |
Custer et al., 2003: Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. Journal of virology. 2003 Sep; 77(18); 9894-905. [PubMed: 12941899 ].
|
|